Αποτελέσματα Αναζήτησης
1. Introduction. Chronic obstructive pulmonary disease (COPD) is an important public health issue in both developed and developing countries. It is an important preventable and treatable disease and poses a heavy socioeconomic burden due to its high morbidity and mortality.[] COPD is the third most common cause of death in the world, according to the World Health Organization (WHO).[]
- An overview of exacerbations of chronic obstructive pulmonary disease ...
Most patients with COPD experience intermittent, acute...
- Chronic Obstructive Pulmonary Disease - StatPearls - NCBI Bookshelf
Objectives: Identify the etiology, epidemiology, and...
- Care of the Hospitalized Patient with Acute Exacerbation of COPD
Most patients who are hospitalized with an exacerbation of...
- Management of COPD exacerbations: a European Respiratory Society ...
This document provides clinical recommendations for...
- An overview of exacerbations of chronic obstructive pulmonary disease ...
3 Απρ 2020 · Most patients with COPD experience intermittent, acute deterioration in symptoms which require additional therapy, termed exacerbations. Exacerbations are prevalent in COPD and are associated with poor clinical outcomes including death, a faster decline in lung health, and a reduced quality of life.
7 Αυγ 2023 · Objectives: Identify the etiology, epidemiology, and pathophysiology of chronic obstructive pulmonary disease (COPD). Recall, analyze, and select appropriate history, physical, and evaluation of chronic obstructive pulmonary disease (COPD). Explain the treatment and management options available for chronic obstructive pulmonary disease (COPD).
Most patients who are hospitalized with an exacerbation of COPD should be treated with systemic corticosteroids, unless side-effects are limiting [I, A]. A dose of prednisone, 40 mg orally daily, for a 5-day course, is appropriate for most patients, and a dose taper is unnecessary (Table 3) [I, A]. Antibiotics.
In chronic obstructive pulmonary disease (COPD), exacerbations (ECOPD), characterized by an acute deterioration in respiratory symptoms, are fundamental events impacting negatively upon disease progression, comorbidities, wellbeing and mortality. ECOPD also represent the largest component of the socioeconomic burden of COPD.
15 Μαρ 2017 · This document provides clinical recommendations for treatment of chronic obstructive pulmonary disease (COPD) exacerbations.Comprehensive evidence syntheses, including meta-analyses, were performed to summarise all available evidence relevant to the Task Force's questions.
12 Ιουλ 2024 · The Global Initiative for Chronic Obstructive Lung Disease (GOLD), a report produced by the National Heart, Lung, and Blood Institute (NHLBI) and the World Health Organization (WHO), defines an exacerbation of chronic obstructive pulmonary disease (COPD) as "an event characterized by dyspnea and/or cough and sputum that worsens over ≤14 days, wh...
